Rallybio Corporation (RLYB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rallybio Corporation

    NASDAQ: RLYB · Real-Time Price · USD
    0.53
    -0.04 (-6.21%)
    At close: Sep 26, 2025, 1:13 PM

    Rallybio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 636K n/a n/a n/a
    Cost of Revenue
    		 131K 150K 167K 109K
    Gross Profit
    		 636K -150K -167K -109K
    Operating Income
    		 -60.5M -78.93M -67.88M -45.65M
    Interest Income
    		 4.22M 6.15M 1.96M 54K
    Pretax Income
    		 -57.77M -74.56M -65.58M -45.51M
    Net Income
    		 -57.77M -74.56M -66.49M -47.01M
    Selling & General & Admin
    		 19.63M 25.39M 27.2M 18.74M
    Research & Development
    		 41.51M 53.39M 40.69M 26.91M
    Other Expenses
    		 n/a 150K n/a n/a
    Operating Expenses
    		 61.13M 78.93M 67.88M 45.65M
    Interest Expense
    		 n/a n/a n/a 10K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 61.13M 78.93M 67.88M 45.65M
    Income Tax Expense
    		 -2.24M -2.04M n/a n/a
    Shares Outstanding (Basic)
    		 43.55M 40.45M 31.82M 32.13M
    Shares Outstanding (Diluted)
    		 43.55M 40.45M 31.82M 32.13M
    EPS (Basic)
    		 -1.33 -1.84 -2.09 -1.46
    EPS (Diluted)
    		 -1.33 -1.84 -2.09 -1.46
    EBITDA
    		 -60.5M -72.37M -65.41M -45.39M
    EBIT
    		 -60.5M -72.52M -65.58M -45.5M
    Depreciation & Amortization
    		 131K 150K 167K 109K

    Add to Watchlist